CFS hydroxylase cofactor levels in some neurological diseases.
- 1 August 1980
- journal article
- research article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 43 (8) , 735-738
- https://doi.org/10.1136/jnnp.43.8.735
Abstract
The cerebrospinal fluid concentration of hydroxylase cofactor has been measured in patients with Parkinson's disease, the Shy-Drager and Steele-Richardson syndromes, adult onset focal dystonia, essential tremor, Huntington's disease and presenile dementia. The results were compared with age matched controls and low values were demonstrated for all disease groups studied except for focal dystonia.This publication has 19 references indexed in Scilit:
- Hydroxylase Cofactor Activity in Cerebrospinal Fluid of Normal Subjects and Patients with Parkinson's DiseaseScience, 1979
- DIALYSIS DEMENTIA, ALUMINIUM, AND TETRAHYDROBIOPTERIN METABOLISMThe Lancet, 1979
- Hyperphenylalaninemia Due to a Deficiency of BiopterinNew England Journal of Medicine, 1978
- SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASEPublished by Elsevier ,1976
- In vivo enhancement of tyrosine hydroxylation in rat striatum by tetrahydrobiopterinNature, 1974
- HUNTINGTON'S CHOREABrain, 1974
- Effect of the beta adrenergic blocking agent propranolol on essential tremorJournal of Neurology, Neurosurgery & Psychiatry, 1973
- Brain Aluminum Distribution in Alzheimer's Disease and Experimental Neurofibrillary DegenerationScience, 1973
- The role of tetrahydropteridines in the enzymatic conversion of tyrosine to 3,4-dihydroxyphenylalanineBiochemical and Biophysical Research Communications, 1964
- ACTION TREMOR AND THE COGWHEEL PHENOMENON IN PARKINSON’S DISEASEBrain, 1963